For: | Traub B, Roth A, Kornmann M, Knippschild U, Bischof J. Stress-activated kinases as therapeutic targets in pancreatic cancer. World J Gastroenterol 2021; 27(30): 4963-4984 [PMID: 34497429 DOI: 10.3748/wjg.v27.i30.4963] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v27/i30/4963.htm |
Number | Citing Articles |
1 |
Jingwei Shi, Xing Yang, Qi Kang, Jian Lu, Maximilian Denzinger, Marko Kornmann, Benno Traub. JNK inhibitor IX restrains pancreatic cancer through p53 and p21. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1006131
|
2 |
Kun Pang, Wei Wang, Jia‐Xin Qin, Zhen‐Duo Shi, Lin Hao, Yu‐Yang Ma, Hao Xu, Zhuo‐Xun Wu, Deng Pan, Zhe‐Sheng Chen, Cong‐Hui Han. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. MedComm 2022; 3(4) doi: 10.1002/mco2.175
|
3 |
Christina Arseni, Martina Samiotaki, George Panayotou, George Simos, Ilias Mylonis. Combinatorial regulation by ERK1/2 and CK1δ protein kinases leads to HIF-1α association with microtubules and facilitates its symmetrical distribution during mitosis. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05120-7
|
4 |
Deepak Sharma, Darbaz Adnan, Mostafa K. Abdel-Reheem, Ron C. Anafi, Daniel D. Leary, Faraz Bishehsari. Circadian transcriptome of pancreatic adenocarcinoma unravels chronotherapeutic targets. JCI Insight 2024; 9(9) doi: 10.1172/jci.insight.177697
|